Summary
Eight untreated patients with an apparent renal-limited disease continued to maintain high titres of ANCA long after the onset of the disease and the start of dialysis. In spite of the high ANCA titres, three of them remained for a long time free of symptoms related to the disease. Three pts developed, at various times from the beginning of the disease, fatal pulmonary hemorrhages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Halma, C., Daha,M.R., Schrama,E. et alii,1989, Antineutrophil cytoplasmic autoantibodies and other laboratory parameters in diagnosis and follow-up of Wegener’s Granulomatosis, Neth J Med 36.
Jayne, D., Heaton, A., Brownlee, A. et alii, 1990, Sequential antineutrophil cytoplasm antibody titres in the management of systemic vasculitis, Nephrol Dial Transplant, 5: 309–310.
Falk, R.J., Hogan, S., Carey T.S. et alii, 1990, Clinical course of anti-neutrophil cytoplasmic autoantibody - associated glomerulonephritis and systemic vasculitis, Ann Intern Med, 113: 656663
Gregorini, G, Tira,P., Tincani, A. et alii, Monitoraggio del titolo degli ANCA nelle vasculiti ANCA positive, GIN, 8: 263–269.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gregorini, G. et al. (1993). Clinical Manifestations in Patients on Chronic Dialysis with High Titres of ANCA. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_83
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9182-2_83
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9184-6
Online ISBN: 978-1-4757-9182-2
eBook Packages: Springer Book Archive